NCT00620620View on ClinicalTrials.gov

Staccato Zaleplon Single Dose Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Inhaled placebo

Inhaled Staccato Placebo

DRUG

Inhaled Zaleplon 0.5 mg

Inhaled Staccato Zaleplon 0.5 mg

DRUG

Inhaled Zaleplon 1 mg

Inhaled Staccato Zaleplon 1 mg

DRUG

Inhaled Zaleplon 2 mg

Inhaled Staccato Zaleplon 2 mg

DRUG

Inhaled Zaleplon 4 mg

Inhaled Staccato Zaleplon 4 mg

Trial Locations (1)

47714

Covance Clinical Research Unit Inc., Evansville

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY

NCT00620620 - Staccato Zaleplon Single Dose Pharmacokinetics | Biotech Hunter | Biotech Hunter